Search Results - "Wright, Eugene E"

Advancements in Diabetes Technology Are Outpacing the Evidence by Rickson, Michael, Wright, Jr, Eugene E, Bindal, Anila, Ghonim, Laith

“…Diabetes technologies such as continuous glucose monitoring (CGM) continue to evolve at an increasingly rapid pace. Seventeen new CGM devices have been…”
Get more information

Is Continuous Glucose Monitoring a Tool, an Intervention, or Both? by Wright, Jr, Eugene E, Subramanian, Savitha

“…Studies that investigate use of diabetes technologies such as blood glucose monitoring (BGM) and continuous glucose monitoring (CGM) often report contradictory…”
Get more information

Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy by Wright Jr, Eugene E., Aroda, Vanita R.

“…Injectable therapies such as glucagon-like peptide-1 receptor agonists (GLP-1RAs) and insulin are high-efficacy options for people with type 2 diabetes (T2D)…”
Get full text

Techniques for Implementing Continuous Glucose Monitoring in Primary Care: Key CGM Updates and Highlights from the ADA 2024 Conference [Podcast] by Wright, Jr, Eugene E

“…This podcast discusses innovations, advancements, and discoveries in continuous glucose monitoring that were presented at the American Diabetes Association 84…”
Get full text

Association of Changes in A1C Following Continuous Glucose Monitoring Acquisition in People with Sub-Optimally Treated Type 2 Diabetes Taking GLP-1 RA Therapy by Miller, Eden, Chuang, Joyce S., Roberts, Gregory J., Nabutovsky, Yelena, Virdi, Naunihal, Wright, Eugene E.

“…Introduction Both glucagon-like peptide-1 receptor agonists (GLP-1 RA) and continuous glucose monitoring (CGM) improve glycemia in patients with type 2…”
Get full text

Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society by Yeung, Andrea M., Huang, Jingtong, Pandey, Ambarish, Hashim, Ibrahim A., Kerr, David, Pop-Busui, Rodica, Rhee, Connie M., Shah, Viral N., Bally, Lia, Bayes-Genis, Antoni, Bee, Yong Mong, Bergenstal, Richard, Butler, Javed, Fleming, G. Alexander, Gilbert, Gregory, Greene, Stephen J., Kosiborod, Mikhail N., Leiter, Lawrence A., Mankovsky, Boris, Martens, Thomas W., Mathieu, Chantal, Mohan, Viswanathan, Patel, Kershaw V., Peters, Anne, Rhee, Eun-Jung, Rosano, Giuseppe M.C., Sacks, David B., Sandoval, Yader, Seley, Jane Jeffrie, Schnell, Oliver, Umpierrez, Guillermo, Waki, Kayo, Wright, Eugene E., Wu, Alan H.B., Klonoff, David C.

“…Diabetes Technology Society assembled a panel of clinician experts in diabetology, cardiology, clinical chemistry, nephrology, and primary care to review the…”
Get full text

Integrating oral semaglutide into clinical practice in primary care: for whom, when, and how? by Brunton, Stephen A., Mosenzon, Ofri, Wright Jr, Eugene E.

“…Oral semaglutide is the first US Food and Drug Administration-approved oral glucagon-like peptide-1 receptor agonist (GLP-1RA) for the treatment of type 2…”
Get full text

Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta‐analysis by Singh, Sonal, Wright, Eugene E., Kwan, Anita Y. M., Thompson, Juliette C., Syed, Iqra A., Korol, Ellen E., Waser, Nathalie A., Yu, Maria B., Juneja, Rattan

“…Aims Since 2005, several glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have been approved to treat people with type 2 diabetes. These agents are…”
Get full text

Empowering Primary Care Practitioners to Lead in Diabetes Care and Management by McCoy, Rozalina G, Wright, Jr, Eugene E, Tan, Piek

“…Nearly 1 in 10 adults worldwide and 1 in 7 adults in the United States are living with diabetes. The central focus of diabetes management is control of…”
Get full text

Where Are We Now? A Clinicians' Guide to the Use of Follow-On Insulin for Patients with Diabetes by Edelman, Steven V., MD, Hollander, Priscilla A., MD, PhD, Wright, Eugene E., MD

“…Abstract Insulin has been used as a standard treatment for patients with diabetes for almost 100 years. Over time, advances in insulin development have…”
Get full text

Clinical Use of Professional Continuous Glucose Monitoring by Wright, Jr, Eugene E, Gavin, 3rd, James R

Get more information

Using Flash Continuous Glucose Monitoring in Primary Practice by Hirsch, Irl B, Wright, Jr, Eugene E

“…Obstacles to realizing the clinical benefits of continuous glucose monitoring (CGM) for daily diabetes management are being overcome with more affordable,…”
Get full text

DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases by Handelsman, Yehuda, Anderson, John E., Bakris, George L., Ballantyne, Christie M., Bhatt, Deepak L., Bloomgarden, Zachary T., Bozkurt, Biykem, Budoff, Matthew J., Butler, Javed, Cherney, David Z.I., DeFronzo, Ralph A., Del Prato, Stefano, Eckel, Robert H., Filippatos, Gerasimos, Fonarow, Gregg C., Fonseca, Vivian A., Garvey, W. Timothy, Giorgino, Francesco, Grant, Peter J., Green, Jennifer B., Greene, Stephen J., Groop, Per-Henrik, Grunberger, George, Jastreboff, Ania M., Jellinger, Paul S., Khunti, Kamlesh, Klein, Samuel, Kosiborod, Mikhail N., Kushner, Pamela, Leiter, Lawrence A., Lepor, Norman E., Mantzoros, Christos S., Mathieu, Chantal, Mende, Christian W., Michos, Erin D., Morales, Javier, Plutzky, Jorge, Pratley, Richard E., Ray, Kausik K., Rossing, Peter, Sattar, Naveed, Schwarz, Peter E.H., Standl, Eberhard, Steg, P. Gabriel, Tokgözoğlu, Lale, Tuomilehto, Jaakko, Umpierrez, Guillermo E., Valensi, Paul, Weir, Matthew R., Wilding, John, Wright, Eugene E.

“…The spectrum of cardiorenal and metabolic diseases comprises many disorders, including obesity, type 2 diabetes (T2D), chronic kidney disease (CKD),…”
Get full text

Time in Range: How to Measure It, How to Report It, and Its Practical Application in Clinical Decision-Making by Wright, Jr, Eugene E, Morgan, Kayla, Fu, Danny K, Wilkins, Nick, Guffey, William J

“…The A1C metric has been the gold standard for assessing glycemia for decades. This biologic assay, based on averaging, is fraught with limitations and may be…”
Get full text

Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study by Bailey, Timothy S, Evenou, Pierre, Gill, Jasvinder, Berhanu, Paulos, Raymond, Romain, Strong, Jodi, Wright, Jr, Eugene E

“…ACHIEVE Control, a prospective, open-label, randomized, pragmatic, real-life study in insulin-naive people with type 2 diabetes (A1C 8.0-11.0%), demonstrated…”
Get full text

The Evolution of Insulin and How it Informs Therapy and Treatment Choices by Hirsch, Irl B, Juneja, Rattan, Beals, John M, Antalis, Caryl J, Wright, Eugene E

“…Abstract Insulin has been available for the treatment of diabetes for almost a century, and the variety of insulin choices today represents many years of…”
Get full text

Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment by Wright, Eugene E, Subramanian, Savitha

“…Numerous studies have demonstrated the clinical benefits of continuous glucose monitoring (CGM) use in individuals with type 1 diabetes and type 2 diabetes…”
Get more information

Results of the Epidemiology of Diabetes Interventions and Complications Trial by Wright, Jr, Eugene E

Get full text

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus by Anderson, John E., Wright, Eugene E., Shaefer, Charles F.

“…Empagliflozin is an oral treatment for type 2 diabetes mellitus (T2DM), one of the leading causes of death in the US and around the world. Recently, the…”
Get full text

Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States by Wright, Eugene E, Nicholas, Susanne B

“…Clinical practice guidelines for the management of chronic kidney disease (CKD) associated with type 2 diabetes (T2D) are designed to assist healthcare…”
Get full text